Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NBRV - Nabriva Is A Buy Before Catalysts


NBRV - Nabriva Is A Buy Before Catalysts

In my previous Nabriva (NBRV) article, I said that Nabriva has two upcoming PDUFAs; the one for Contepo on April 30, 2019, and another for lefamulin on August 19, 2019. I also said that while approval is almost a certainty, the general condition of the antibiotic market makes us less convinced about the stock’s long-term potential.

While I gave my reasons for that argument, readers latched on to my negative long-term view. What they did not take into account was that I also implied that Nabriva may be a good catalyst investment

Read more ...

Stock Information

Company Name: Nabriva Therapeutics plc
Stock Symbol: NBRV
Market: NASDAQ

Menu

NBRV NBRV Quote NBRV Short NBRV News NBRV Articles NBRV Message Board
Get NBRV Alerts

News, Short Squeeze, Breakout and More Instantly...